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 Abstract 
When mouse embryonic stem cells (ESCs) were grown on mitotically inactivated rat 
umbilical cord-derived stromal cells (RUCs) in the absence of leukemia inhibitory factor (LIF) 
and 2-mercaptoethanol (2-MCE), the ESCs showed alkaline phosphatase (AP) staining.  ESCs 
cultured on RUCs maintain expression of the following pluripotency genes, Nanog, Sox2 and 
Oct4 and grow at a slower rate when compared with ESCs grown on mitotically inactivated 
mouse embryonic fibroblasts (MEFs).  Differences in gene expression for the markers of 
pluripotency Oct4, Sox2 and Nanog, AP staining and ESC growth rate were also observed after 
LIF and 2-MCE were removed from the co-cultures.  Reverse transcriptase polymerase chain 
reaction (RT-PCR) suggested differences in Sox2 and Nanog mRNA expression, with both genes 
being expressed at higher levels in the ESCs cultured on RUCs in the absence of LIF/2-MCE as 
compared to ESCs cultured on MEFs.  Semi-quantitative RT-PCR indicated that Nanog 
expression was higher when ESCs were grown on RUCs in the absence of LIF and 2-MCE as 
compared to MEFs in the same treatment conditions.  Bisulfite-mediated methylation analysis of 
the Nanog proximal promoter suggested that the maintenance of Nanog gene expression found in 
ESCs grown on RUCs after culture for 96 hours in the absence of LIF/2-MCE may be due to 
prevention of methylation of the CpG dinucleotides in the Nanog proximal promoter as 
compared to ESCs grown on MEFs.  Thus, RUCs may release factors into the medium that 
maintain the pluripotent state of mouse ESCs in the absence of LIF and 2-MCE.
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 CHAPTER 1 - Literature Review 
Introduction: Embryonic Stem Cells 
This review will focus on embryonic stem cells (ESCs) derived from the mouse.  Unless 
otherwise stated, all references are to mouse ESCs.  The ability to maintain the pluripotent state 
in ESCs allows homologous recombination-mediated targeted genetic manipulation and the 
creation of gene-specific disease models (Evans et al., 2001;Zwaka and Thomson, 2003).  The 
first hint of ESCs came with the description of serially transplantable teratoma cells in the 129 
strain mouse (Solter, 2006;Stevens and Little, 1954).  Some teratocarcinoma cell lines resemble 
closely ESCs in that among others things, they were able to form embryoid bodies and contribute 
to chimera formation (Martin and Evans, 1975).  The stem cells of teratocarcinomas are known 
as embryonal carcinoma (EC) cells which contribute inefficiently to the germ line (Bradley et al., 
1984).  Martin Evans’ lab reported the first ESCs from the 129 SvE mouse strain in the same 
year as Gail Martin (Evans and Kaufman, 1981; Martin, 1981).  ESCs were limited to the mouse 
species until 1998 (Thomson et al., 1998).  Even within the mouse species, derivation of ESCs 
from strains other than the Sv129 strain was difficult until the importance of mitogen-activated 
protein kinase kinase (MEK) and glycogen synthase kinase 3 beta (GSK3B) inhibition for 
maintaining the pluripotent state was recognized (Sato et al., 2004;Smith, 2001).  ESCs have 
been derived from different mouse strains by the combination of MEK and GSK3B inhibition 
(Buehr et al., 2008;Ying et al., 2008). 
Oct4, Sox2 and Nanog Expression and Alkaline Phosphatase (AP) Activity in 
Mouse ESC Pluripotency 
The importance of the transcription factors Pit-Oct-Unc (POU) domain, class 5, 
transcription factor 1 (POU5F1 or Oct4), SRY (sex determining region Y)-box 2 (Sox2) and 
Nanog in maintaining the pluripotent state of ESCs can be seen in their ability to cause a change 
in the expression program in, or reprogram, non-pluripotent cells to the pluripotent state 
(Nakagawa et al., 2008;Yu et al., 2007;Zhou et al., 2009).  Expression of Oct4, Sox2 and Nanog 
are required for the maintenance of mouse and human ESCs in culture (Boyer et al., 2005; 
Ivanova et al., 2006).  MicroRNA (miRNA) that causes the downregulation of Oct4, Sox2 and 
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Nanog mRNA modulate ESC differentiation (Tay et al., 2008).  Short hairpin RNA (shRNA) 
knockdown of Oct4, Sox2 and Nanog expression causes ESC differentiation, and overexpression 
of Oct4 and Sox2 also causes differentiation (Boer et al., 2007; Niwa et al., 2000).    
ESCs also show heterogeneity within a single colony where the “less” differentiated zinc 
finger protein 42-positive (Zfp42 or Rex1) cells express higher levels of Nanog, Sox2 and Oct4 
(Toyooka et al., 2008).  Oct4 expression at a certain level is required for self-renewal and 
prevention of differentiation of ESCs (Niwa et al., 2000).  Homozygous deficiency of Oct4 in 
vitro prevents the outgrowth of the inner cell mass (ICM) (Nichols et al., 1998).  Overexpression 
of Oct4 reduces Nanog gene expression as shown by reduced Nanog reporter expression 
following increases in Oct4 transgene dosage (Pan et al., 2006).  Oct4 is expressed in the oocyte, 
in the ectoderm of the egg cylinder stage and restricted to the primordial germ cells (PGC) after 
8.5 dpc (Scholer et al., 1990).  Oct4 expression can be stimulated in trophoblast stem cells with 
DNA methyltransferase (DNMT) inhibitor 5-aza-dC and histone deacetylase 1 (HDAC1) 
inhibitor trichostatin A (TSA) (Hattori et al., 2004).   
Sox2 is expressed in embryonal carcinoma (EC) cells and ESCs (Yuan and Dailey, 
1995).  Sox2 null mice, such as homozygous knockouts, did not show outgrowth of the ICM 
when blastocysts were cultured in vitro (Avilion et al., 2003).  The absence of ICM outgrowths 
can be explained by the differentiation of the ICM to trophectoderm-like cells (Masui et al., 
2007).  Transgene electroporation of exogenous Oct4 rescued the proliferation of the Sox2 null 
ESCs, but Nanog did not show a rescue effect, suggesting that Oct4 can substitute for Sox2 and 
that a functional Sox2 is required for the Nanog-mediated prevention of differentiation 
mentioned above.   shRNA knockdown of Sox2 results in differentiation of mouse ESCs 
(Ivanova et al., 2006).  Overexpression of Sox2 reduces the expression of Oct4-Sox2 target 
genes, including Oct4, Sox2 and Nanog (Boer et al., 2007).  Sox2 is expressed widely in the 6.5 
to 8.0 dpc embryo and is also strongly expressed in neural stem cells (Kim et al., 2008; Wood 
and Episkopou, 1999).  Sox2 is expressed in the brain, retina, lung and stomach (Yuan et al., 
1995).  Oct4 and Sox2 are expressed in the regenerating rat epithelium (Song et al., 2009).   
The Nanog gene is expressed in embryonic tissues from 3.5 - 8.5 dpc and is relatively 
strongly expressed in the ovary, testis, kidney liver and spleen (Hart et al., 2004).  It is also 
expressed in ESCs, embryonic germ cells and EC cells and decreases during ESC differentiation 
(Chambers et al., 2003;Mitsui et al., 2003).  It is required for the maintenance of pluripotency.  
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Nanog deficiency in vitro results in differentiation (Mitsui et al., 2003).  Overexpression of 
Nanog can maintain ESC pluripotency in the absence of other pluripotency associated factors 
(Ivanova et al., 2006).  In fact, Nanog overexpression alone has been found to reduce 
differentiation of ESCs under differentiation-inducing conditions (Chambers et al., 2003;Ivanova 
et al., 2006).  This effect is also seen in the absence of leukemia inhibitory factor (LIF) (Mitsui et 
al., 2003).  Nanog maintains pluripotency through activation of signal transducer and activator of 
transcription 3 (Stat3) and repression of nuclear factor of kappa light polypeptide gene enhancer 
in B-cells (NF-Kb) (Torres and Watt, 2008).   
Two forms of alkaline phosphatase (AP) are expressed during early mouse development, 
alkaline phosphatase placental-like 2 (Alppl2) and alkaline phosphatase liver/bone/kidney (Alpl), 
the latter also known as tissue-non-specific AP (TNAP) (Hahnel et al., 1990).  Alppl2 is found in 
2-cell and 8-cell embryos, blastocysts, adult testis and thymus.  Disruption of Alppl2 causes a 
slight delay in the cellular proliferation of the pre-implantation embryo (Dehghani et al., 2000).  
The Alpl gene is not expressed in the mouse 3.5 days post-coitum (dpc) blastocyst; the protein is 
primarily restricted to the mural trophectoderm in 4.5 dpc blastocyst, the extraembryonic 
ectoderm in 5.5 and 6.5 dpc embryos, and is found in primordial germ cells (PGCs), the adult 
testis and the thymus (Hahnel et al., 1990;MacGregor et al., 1995).  In the MacGregor study, 
Alpl or TNAP was observed in the inner cell mass (ICM) outgrowths that were in contact with 
the trophectoderm-derived cells and was never observed in blastocysts.  The above suggests that 
Alppl2 is expressed in the ESCs. 
Oct4, Sox2 and Nanog Expression, and Alkaline Phosphatase (AP) Activity 
during Differentiation of Mouse ESCs  
The transcription factors Oct4, Sox2 and Nanog play important roles in ESC self-
renewal.  Oct4 gene expression is not downregulated even after culture of ESCs in the absence of 
LIF for 4 weeks in a feeder-free ESC culture system (Berrill et al., 2004).  Other studies have 
also found that ESC expression of the Oct4 gene was not completely downregulated after four or 
five days of culture in the absence of LIF (Faherty et al., 2007; Hamazaki et al., 2004).  In the 
Hamazaki et al. study, Nanog gene expression, as determined by gel electrophoresis RT-PCR, 
was found to be downregulated to a greater extent, though not completely abolished, as 
compared to the downregulation of Oct4 gene expression (Kaji et al., 2006).  Another study 
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found that ESCs lose Nanog and Oct4 gene expression after culture in the absence of LIF for two 
passages (Kawazoe et al., 2009).  These studies suggest that the expression of the Oct4 gene is 
maintained for up to four days of culture in the absence of LIF and that the expression of the 
Nanog gene is also maintained, or possibly partially downregulated, for up to four days of 
culture in the absence of LIF.  Sox2 expression was found to be downregulated to 40% of control 
after 10 days of embryoid body culture in the absence of LIF (Wu et al., 2009).   
The expression of Oct4, Sox2 and Nanog genes may be downregulated at an accelerated 
rate after RA treatment.  In ESCs, Nanog gene expression decreases nearly 10 fold and Oct4 
gene expression decreases >10 fold after only 120 hours of RA treatment (Lin et al., 2005).  
Sox2 gene expression is completely abolished in ESCs after five days of retinoic acid (RA)-
induced differentiation (Maruyama et al., 2005).  RA-induced differentiation of ESCs is also 
accompanied by downregulation of the Oct4 and Sox2 protein levels (Chew et al., 2005).   In the 
Chew et al. study, after 3 days of RA treatment, there was downregulation of Oct4 and Sox2 
protein levels and after 6 days of RA treatment, Oct4 protein was undetectable and Sox2 protein 
was nearly abolished.  This is in line with chromatin immunoprecipitation studies in ESCs that 
analyzed the binding of the Oct4 and Sox2 proteins to the oct-sox binding element within the 
Nanog gene promoter.  This study showed that after 3 days of RA treatment, the binding of both 
Oct4 and Sox2 proteins to the oct-sox binding element was reduced by 75% and after 6 days of 
RA treatment, binding was reduced to <10% (Rodda et al., 2005).  RA treatment for 3 days 
nearly abolishes Nanog protein levels (Kuroda et al., 2005). 
LIF and Feeder Cells in Pluripotency and Differentiation  
Fibroblasts were first used as a feeder layer to support embryonal carcinoma (EC) cells 
which die after two or three passages in the absence of fibroblasts.  EC grow indefinitely when 
plated on a feeder layer made from mitotically inactivated STO fibroblasts (Martin and Evans, 
1975).  STO is a thioguanine and ouabain resistant fibroblast cell line derived from the SIM 
mouse (ATCC).  A STO feeder layer alone was found to be insufficient to maintain ESCs in the 
undifferentiated state in the absence of conditioned media from teratocarcinoma cultures (Martin, 
1981).  Martin speculated that there was a secreted factor in the teratocarcinoma cultures.  The 
conditioned medium from buffalo rat liver cell cultures also prevents the differentiation of ESCs 
in the absence of feeders (Smith and Hooper, 1987).  The conditioned medium contained a 
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molecule termed polypeptide with differentiation inhibiting activity (DIA).  Leukemia inhibitory 
factor (LIF) was discovered in 1988 through analysis of homology to DIA (Smith et al., 
1988;Williams et al., 1988). 
LIF belongs to the interleukin 6 (IL-6) family of cytokines (Kristensen et al., 2005;Rose 
and Bruce, 1991).  An autocrine loop is involved in LIF maintenance of pluripotency (Davey et 
al., 2007).  LIF stimulates the cell surface receptor gp130 and signals through the intracellular 
Janus kinase-signal transducer and activator of transcription (JAK-STAT) and rat sarcoma viral 
oncogene homolog-mitogen activated protein kinase (RAS-MAPK) pathways (Ernst et al., 
1996).  Loss of signaling downstream of JAK-STAT reduces proliferation, and hyper-activation 
of JAK-STAT results in tumors (Harrison et al., 1995).  In ESCs, decrease in alkaline 
phosphatase (AP) staining begins at concentrations of LIF less than 250 IU/mL (Zandstra et al., 
2000).  With complete LIF removal, associated phosphorylated STAT3 levels drop to ~50% by 
24 hours and Oct4 expression decreases to less than 60% by 60 hours (Davey et al., 2007).  Of 
the cells found to express Oct4, less than 65% were positive for Nanog expression.   
The conditioned medium from serum-free cultured STOs contains cell trophic factors 
including insulin growth factor binding protein 4 (IGFBP-4), pigment epithelium derived factor 
(PEDF) and secreted acidic cysteine rich glycoprotein (SPARC) and the antioxidant 
peroxiredoxins (Lim and Bodnar, 2002).  MEFs derived from the CF-1 mouse strain have been 
shown to secrete transforming growth factor, beta 1 (TGFβ1) and inhibin beta dimers (activin A) 
and low levels of bone morphogenetic protein 4 (BMP-4) (Eiselleova et al., 2008).  Human 
umbilical cord-derived stromal cells (HUCs) express various trophic factors and cytokines, and 
have been used support the maintenance primate ESCs (Hiroyama et al., 2008;Weiss et al., 
2008).  Bovine umbilical cord-derived stromal cells have used to derive ESCs from the equine 
blastocysts (Saito et al., 2002).  Here, I will evaluate whether rat umbilical cord-derived stromal 
cells (RUCs) can maintain mouse ESCs in the pluripotent state. 
2-Mercaptoethanol (2-MCE) Effects on Proliferation and Apoptosis  
In the culture of in vitro fertilized porcine embryos, the average number of cells per 
blastocyst was increased in cultures with 50 uM 2-MCE as compared to controls, though the 
percentage of embryos developing to the blastocyst stages was lower (Funahashi, 2005).  This 
increase in average number of cells per blastocyst was also seen in culture after thaw of vitrified 
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bovine blastocysts, and the viability of post-thaw bovine blastocysts was higher in the presence 
of 2-MCE (Nedambale et al., 2006).  The average number of cells in the ICM is also increased in 
the presence of 2-MCE as well as a decrease in the number of apoptotic blastomeres in bovine 
embryos (Park et al., 2004).  Withdrawal of 2-MCE promotes apoptosis in a B-cell line via 
upregulation of TNF receptor superfamily member 6 (Fas) and Fas ligand and increases the 
percentage of cells arrested in G0/G1 of the cell cycle (Neumann et al., 1998).  2-MCE also 
induces increases in DNA content in cultures of primary human bone marrow adherent cells 
which may be associated with increased proliferation as determined by 3H thymidine 
incorporation assays (Inui et al., 1997). 
Promoter Methylation  
CpG islands were coincident with ~60% of promoters for genes transcribed by human 
RNA polymerase II (Antequera and Bird, 1993).  These islands are protected from CpG 
suppression characterized by high CpG content (65% G+C).  Methylated cytosines were 
recognized and bound by a family of methylation dependent DNA binding proteins (MBPs) 
whose binding can initiate transcriptional repression (Chandler et al., 1999;Horike et al., 
2005;Ng et al., 1999).  Prior in vitro methylation of specific cytosines in a reporter transgene 
results in its reduced promoter activity (Martinowich et al., 2003).  These studies suggest that 
methylation of the promoters is not an all-or-nothing process (Boyes and Bird, 1992).  
Methylation of cytosines occurs in the Oct4 proximal promoter after differentiation (He et al., 
2009; Gu et al., 2006).  For Nanog, the percentage of methylated CpG dinucleotides within a 526 
bp stretch of the proximal promoter is decreased from 27% in the one-cell zygote to 2.2% in the 
blastocyst (Farthing et al., 2008).   In the same study, it was shown that the increased 
methylation of the Nanog upstream activation sequence (UAS) to 40.9% in a reporter transgene 
was associated with reduced expression of the transgene. 
RT-PCR and Semi-quantitative RT-PCR  
Polymerase chain reaction (PCR) allows the amplification of cDNA which is 
representative of the mRNA for a gene present in a cell.  RNA is collected from a cell pellet 
using various commercial kits.  These kits are based on RNA-specific binding to a silica column 
and contain RNase inhibitors in proprietary buffers (Qiagen).  Purified RNA is comprised of 
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various species of RNA molecules with ribosomal RNA accounting for the majority.  mRNA 
comprise 1-5% of the total RNA (Sambrook et al., 2001).  cDNA synthesis of RNA is performed 
with reverse transcriptases.  Reverse transcriptases require Mg2+ cofactor and primers.  Oligo-
dT oligonucleotides, which bind the poly-A tail of mRNA, or random hexamer oligonucleotides, 
serve as the primer for the reverse transcription.   
The calculation of band pixel numbers, or densitometry, of agarose gel photographs can 
provide semi-quantitative data of cDNA mass by reference to known quantity DNA ladders 
(Bautista et al., 2009).  Semi-quantitative PCR can quantify the relative differences in starting 
cDNA copy number which can be automatically calculated (Peirson et al., 2003;Stahlberg et al., 
2004;Tichopad et al., 2003).  For absolute quantification of cDNA, this must be performed after 
primer efficiency analysis, validated control genes and with reference dye loading controls 
(Bustin et al., 2009;Reece et al., 2009).   
Summary  
Stem cell research is an exciting area.  The FDA has approved a clinical trial for a human 
ESC derivative for the treatment of complete thoracic spinal cord injury 
(www.geron.com/media/pressview.aspx?id=1195).  Researchers are forging ahead in this stem 
cell transplantation approach to disease therapy, but progress into the clinic is painstakingly 
meticulous due to the potential for tumor formation (Lensch et al., 2007).   
Mouse ESCs must be pluripotent in order to contribute to the germline after blastocyst 
injection.  Pluripotency can be maintained in vitro when ESCs are cultured on a feeder layer of 
mouse embryonic fibroblasts (MEFs) with the supplementation of leukemia inhibitory factor 
(LIF).  Previous work has shown that removal of LIF and associated loss of JAK-STAT 
signaling reduces proliferation and reduces Oct4 expression to less than 60% by 60 hours.   
Expression analysis of the transcription factors Oct4, Sox2 and Nanog, along with 
alkaline phosphatase staining, can identify putative pluripotent stem cells.  Oct4, Sox2 and 
Nanog are each required for the maintenance of ESCs pluripotency in vitro.  Oct4 and Sox2 
deficiency prevents the outgrowth of the ICM and Nanog deficiency results in differentiation.  
Overexpression of Oct4 results in differentiation of mouse ESCs whereas overexpression of a 
Nanog transgene is sufficient to maintain mouse ESCs in the absence of LIF.  The culture of 
ESCs in the absence of LIF for four days does not downregulate Oct4 gene expression.  This is 
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also true for Nanog gene expression as RT-PCR has shown continued Nanog gene expression 
after culture of ESCs in the absence of LIF for our days.  Sox2 gene expression in ESCs cultures 
in the absence of LIF for 10 days in an embryoid body assay is reduced to 40%. 
Subtle changes in expression and crosstalk affect cell fate, such as the pluripotent state.  
In mouse ESCs, increasing Oct4 gene expression reduced Nanog reporter expression.  
Overexpression of Sox2 decreases the expression of Oct4, Sox2 and Nanog genes and increasing 
the Sox2 transgene 3-fold caused further reduction in expression.  These effects of gene dosage 
can be seen in the heterogeneity of ESCs with the Rex1-positive cells showing relatively higher 
levels of Nanog, Sox2 and Oct4 gene expression (Toyooka et al., 2008).  Detailed 
characterization of the optimal levels of Oct4, Sox2 and Nanog expression would have 
applications in increasing the efficiency of selecting pluripotent embryonic as well as induced 
pluripotent stem cells for transgenesis or differentiation to adult tissue. 
Methylated DNA is generally thought to represent heterochromatin which is considered 
silent or transcriptionally repressed.  The downregulation of Oct4 and Nanog gene expression 
during differentiation from the pluripotent state is accompanied by methylation of CpGs in their 
respective proximal promoters.  This silencing can be initiated by binding of methylation 
dependent DNA binding proteins (MBPs) to symmetrically methylated CpG dinucleotides and 
may not necessitate the complete methylation of all cytosines in the regulatory region of the 
genes being silenced.   
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CHAPTER 2 - Introduction 
Mouse embryonic stem cells (ESCs) can be maintained indefinitely in the 
undifferentiated state when cultured on mitotically inactivated mouse embryonic fibroblasts 
(MEFs) with leukemia inhibitor factor (LIF) supplementation (Martin and Evans, 1975;Smith et 
al., 1988;Williams et al., 1988).  The combination of alkaline phosphatase (AP) histochemical 
staining and Oct4, Sox2 and Nanog expression can be used to distinguish putative pluripotent 
stem cells (Masui et al., 2007;Nakagawa et al., 2008;O'Connor et al., 2008).   
Recently, it has been suggested that the ESC colonies are heterogeneous (Hayashi et al., 
2008).  This heterogeneity is affected by the culture microenvironment (Chou et al., 2008).  This 
microenvironment includes the feeder layers or feeder cells that support the growth of ESCs.  
The use of cells to support the growth of ESCs has evolved from the use of a fibroblast cell line 
derived from the SIM mouse (STO) and the addition of conditioned media from embryonal 
carcinoma cultures to the invention of feeder-free and serum-free cultures under defined 
conditions (Ludwig et al., 2006;Xu et al., 2001).  Different feeder types have been used to 
support the growth of ESCs.  These include stromal cells from the umbilical cord blood, buffalo 
rat liver cells and immortalized human foreskin fibroblasts, which all share a mesodermal lineage 
(Eiselleova et al., 2008;Smith and Hooper, 1987;Ye et al., 1994).   
Our lab works with human umbilical cord matrix stromal cells (HUC) which have been 
shown to secrete cytokines in vitro (Weiss et al., 2008).  Here, the rat umbilical cord matrix-
derived stromal cells (RUCs) were compared to MEFs for their ability to support the 
undifferentiated state and proliferation of two mouse ESC lines.  There is previous work with 
bovine umbilical cord-derived matrix cells in the derivation of ESC from equine blastocysts 
(Saito et al., 2002). 
To analyze the effects of LIF/2-MCE removal on the pluripotent state of ESCs cultured 
on RUCs as compared to ESCs cultured on MEFs, AP histochemical staining, ESC growth and 
Oct4, Sox2 and Nanog expression were evaluated.  When ESCs were co-cultured with 
mitotically inactivated RUCs, they grew as 3-dimensional, phase-bright colonies resembling the 
morphology of ESCs grown on MEFs.  AP histochemical staining indicated RUCs were able to 
maintain the in vitro pluripotent state of two different mouse ESCs, the D3 and LC3 cell lines, in 
contrast to MEFs which showed reduced AP staining after removal of LIF/2-MCE.  Gel 
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electrophoresis of RT-PCR showed bands for Oct4, Sox2 and Nanog during RUC co-culture and 
semi-quantitative RT-PCR suggested the Nanog and Sox2 genes were downregulated after 
LIF/2-MCE removal when ESCs were cultured on MEFs.  Analysis of the methylation of the 
Nanog proximal promoter supported the hypothesis that the Nanog gene was being expressed 
when grown on RUCs in the absence of LIF/2-MCE and indicated increased methylation when 
ESCs were cultured on MEFs in the absence of LIF/2-MCE.  It is concluded that RUCs were 
able to maintain mouse ESCs in a pluripotent state in vitro, perhaps by the release of cytokines 
such as LIF, and that this model may prove useful in the characterization of the timing of the 
methylation of the proximal Nanog promoter in mouse ESCs during differentiation.   
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CHAPTER 3 - Methods 
Cell Culture 
Mouse embryonic fibroblasts (MEFs) (ATCC SCRC 1008, day 15, lot 7379965) from 
passages 1 through 4 were mitotically inactivated by exposure to 10 ug/mL of mitomycin C 
(MMC, Sigma-Aldrich, M4287-2MG) for 2.5 hours.  Mitotically inactivated MEFs were rinsed 
with PBS, lifted with 0.25% Trypsin with 0.38 g/L of EDTA (Invitrogen, 25200-106) and frozen 
in 10% DMSO and 90% MEF medium in a controlled freezing device at >500,000 cells per vial 
to -80oC, then moved to liquid Nitrogen at -196oC until use.  To use, the cryovials were thawed 
rapidly in a water bath at 37oC until a pea-sized ice crystal remained and the contents diluted 
with 3 volumes of culture medium and plated in MEF medium pre-warmed to 37oC and pre-
equilibrated in 5% CO2.  Rat umbilical cord-derived stromal cells (RUCs) were isolated from the 
gestation day 21 rat fetal umbilical cord in our lab after hysterectomy.  RUCs were grown in 
MEF medium prior to inactivation.  RUCs were inactivated at passage 33 and 34 by exposure to 
MMC for 5 ug per mL for 1 hour, rinsed with PBS and frozen as described above for MEFs.  
Mouse embryonic stem cells (ESCs) (D3, ATCC, CRL-11632 at passage 5 and LC3, 
GlobalStem, GSC-5002 at passage 11) were grown in ESC medium: high glucose DMEM 
(Gibco, Invitrogen, 11965-073) with 10% heat-inactivated Fetal Bovine Serum (HyClone, 
300071-03, SH30071.03), 1% Non-essential amino acids (Gibco, Invitrogen, 11140-050), 2 mM 
Glutamax (Invitrogen, 35050-061), 86 uM 2-mercaptoethanol (Sigma-Aldrich, M7522, 
Nedambale et al., 2006) and 500 IU/mL mouse leukemia inhibitory factor (Chemicon, ESG1106).  
MEFs were grown in MEF medium: high glucose DMEM (Gibco, Invitrogen, 11965-073) with 
10% heat-inactivated Fetal Bovine Serum (HyClone, 300071-03, SH30071.03), 1% Non-
essential amino acids (Gibco, Invitrogen, 11140-050), and 2 mM Glutamax (Invitrogen, 35050-
061).   
Plating MEF or RUC feeder layers 
6-well (BD Falcon, ThermoFisher, 08-772-1B) and 12-well plates (Corning Costar, 
ThermoFisher, 07-200-82) were coated with 0.1% bovine gelatin (Sigma-Aldrich, G2500-500) in 
single distilled water by adding 1 mL of the gelatin solution per well.  Gelatin was aspirated 
immediately, 1500 uL per well of 6-well plates and 750 uL per well of 12-well plates of MEF 
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medium was added immediately and the plate was placed into the incubator to equilibrate at 5% 
CO2, 37oC and 90% humidity for 15 minutes.  Both mitotically inactivated MEFs and RUCs 
were plated at either one of two densities in MEF medium on gelatin-coated plates (12,500 or 
25,000 cells per cm2, figure 3-1).  Twenty four (24) hours after plating the feeder layer, MEF 
medium was replaced with ESC medium.  Twenty four (24) hours after replacing with ESC 
medium, ESCs were plated at 500 cells per cm2 and cultured for a total of five days.  Medium 
changes (complete replacement) were at 24 hours and 72 hours after plating ESCs.  In some 
cases, ESC medium was replaced with ESC medium without LIF and 2-MCE (figure 3-1).  All 
cells were harvested at 120 hr.  Thus, three experimental conditions were made: 1) ESC medium 
for 120 hr, and 2) 48 and 3) 96 hour LIF-2-MCE deprivation conditions.   
Alkaline Phosphatase (AP) Staining 
At the end of the experiment (120 hr after plating ESCs), wells were fixed with 4% 
paraformaldehyde (ThermoFisher Scientific, 04042-500) in 0.05M Sorenson’s phosphate Buffer, 
pH 7.2-7.4, for <2 minutes at room temperature, rinsed with PBS and stained with an AP 
staining kit according to the manufacturer’s instructions (Millipore, SCR004).  All plates were 
photographed using a 55 mm Nikkor macro lens from a distance of 0.25 meters and these 
photographs were used to count colonies using a grid method as illustrated (Figure 3-2).  
Intensely stained colonies within the grid were counted.  Diffusely staining colonies were not 
included in the analysis.  Counting was done by two investigators (one investigator was blind to 
the experimental conditions; there was no significant differences between the counts of the two 
investigators, data not shown) and their counts were averaged.  For all experiments, an n of 1 is 
comprised of three wells, one well each for control conditions (supplemented continuously with 
LIF/2-MCE) and two treatment conditions where ESCS were grown in the absence of LIF/2-
MCE for 48 hours or 96 hours.  n = 5 for D3 cultured on MEFs plated at 12,500/cm2, n = 4 for 
D3 cultured on MEFs plated at 25,000/cm2, n = 4 for D3 cultured on RUCs plated at 12,500/cm2, 
n = 5 for D3 cultured on RUCs plated at 25,000/cm2, n = 3 each for LC3 cultured on MEFs 
plated at 12,500/cm2 and 25,000/cm2 and n = 3 each for LC3 cultured on RUCs plated at 
12,500/cm2 and 25,000/cm2. 
Cell Counts 
 12
At the end of the experiment (120 hr after plating ESCs), wells were washed with PBS, 
and the cells were lifted using 0.25% Trypsin (Invitrogen, 25200-106).  Trypsin was inactivated 
by rinsing with 3 volumes of medium and the cells from all conditions were resuspended in ESC 
medium with LIF and 2-MCE.  D3 ESCs were counted using a hemocytometer and 0.2% Trypan 
Blue stain (Sigma-Aldrich, T8154).  LC3 ESCs were counted using a Guava EasyCyte Plus and 
the Guava Viacount assay according to the manufacturer’s instructions (Millipore, 4000-0041).  
n = 3 each for D3/LC3 cultured on MEFs plated at 12,500/cm2 and 25,000/cm2 and n = 3 each 
for D3/LC3 cultured on RUCs plated at 12,500/cm2 and 25,000/cm2. 
Gel Electrophoresis and Reverse transcriptase polymerase chain reaction 
(RT-PCR) 
At the end of the experiment (120 hr after plating ESCs), to lift cells, wells were washed 
with PBS and treated with 0.05% Trypsin with 0.08 g/L of EDTA (this concentration of Trypsin 
and EDTA minimizes the lifting of feeders; not shown), and Trypsin inactivated with 3 volumes 
of ESC medium.  The cells were spun at 1000 rpm for 3 minutes.  The resulting cell pellet was 
used for RNA isolation.  Total RNA was collected using the RNeasy Midi Kit (Qiagen, 75144).  
RNA was treated with DNase (Qiagen, 79254) on column for 15 minutes at room temperature to 
remove genomic DNA.  The RNA was quantified using Nanodrop 8000.  At least 5 ug of total 
cDNA for each RNA sample was made using Superscript III First-Strand Synthesis Supermix 
(Invitrogen, 18080-400) primed with oligo-dT using a BioRad iCycler: 65oC incubation for 5 
minutes, 50oC cDNA synthesis for 50 minutes and 85oC termination for 5 minutes in a total 
reaction volume of 22 uL in MicroAmp 8-tube strips (Applied Biosystems, N8010580).  cDNA 
samples were stored at -20oC.  RT-PCR was carried out using a BioRad iCycler with a 96-well 
block as per the following using 4 ng of template DNA and 0.5 units of REDTaq polymerase and 
2 uL REDTaq PCR Reaction Buffer containing 11 mM MgCl2 (Sigma, D4309) with 0.5 uM 
primer mix and 0.25 mM dNTP in a total reaction volume of 20 uL: 95oC denaturing for 3 
minute and then cycled between 95oC denature for 30 seconds, 55oC annealing for 30 seconds 
and 72oC 30 seconds for extension for a total of 35 cycles, followed by 72oC for 10 minutes for 
final extension in MicroAmp 8-tube strips (Applied Biosystems, N8010580).  The RT-PCR 
products were held at 4oC prior to resolving on 1.0% agarose gels containing 0.75 ug/mL 
solution of Ethidium Bromide (Sigma-Aldrich, E8751).  Nine (9) uL of the RT-PCR products for 
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each sample were loaded into the agarose gels along with 6 uL of DNA ladder (Promega, 
G2101).  For RNA collection, n = 4 for D3s cultured on MEFs and n = 3 for D3s cultured on 
RUCs.  For RT-PCR, n = 1 for D3s cultured on MEFs plated at 12,500 cells/cm2, n = 1 for D3s 
cultured on MEFs plated at 25,000 cells/cm2, n =1 for D3s cultured on RUCs plated at 12,500 
cells/cm2 and n = 1 for D3s cultured on RUCs plated at 25,000 cells/cm2. 
Semi-quantitative RT-PCR 
Semi-quantitative RT-PCR for Nanog gene expression was performed using 4 ng and 0.4 
ng of cDNA per reaction tube containing reference dye and performed in duplicate using the 
RT2 SYBR® Green qPCR Master Mix according to the manufacturer’s recommendation 
(SABiosciences, PA-011) using the BioRad iCycler and the cycle threshold (Ct) method.  Semi-
quantitative RT-PCR for Sox2 gene expression was performed using 9.4 ng of cDNA per 
reaction tube containing reference dye using the RT2 SYBR® Green qPCR Master Mix 
according to the manufacturer’s recommendation (SABiosciences, PA-010) using the BioRad 
iCycler and the cycle threshold (Ct) method.  Ct values represent the cycle at which the 
fluorescence of the sample exceeds the background fluorescence of the reference dye determined 
prior to the first amplification cycle as measured by the BioRad iCycler.  delta Ct was calculated 
by subtracting the average Ct value of the sample from the average Ct value of the control gene.  
Semi-quantitative RT-PCR was carried out with an initial denature step at 95oC for 15 minutes, 
45 cycles of denature at 95oC for 15 sec, annealing at 52oC for 15 sec and extension at 60oC for 1 
minute in a total reaction volume of 25 uL in MicroAmp 8-tube strips (Applied Biosystems, 
N8010580). The expression of three different genes was evaluated to determine which would be 
appropriate to use as a control gene here: 18S ribosomal RNA (X00686), hydroxymethylbilane 
synthase (PBGD or HMBS) (NM_013551.2) and aminolevulinic acid synthase 1 (ALAS) 
(NM_020559).  The standard deviation for 18S expression was lowest across all experimental 
conditions (figure 4-6B).  Based upon this criterion, 18S was selected as the control gene for 
semi-quantitative RT-PCR.  The primers used in these experiments are shown in Table 3-1. 
Nanog proximal promoter methylation analysis 
The methylation protocol was as described previously for the rat Oct4 promoter (He et 
al., 2009).  The primer set used for the amplification of the Nanog proximal promoter produced a 
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630 bp fragment referenced to Genebank number: NT_039353.7|Mm6_39393_37.  The primers 
are shown in Table 3-1.  n = 1 for D3 cultured on MEFs and n = 1 for D3 cultured on RUCs.  
Plasmid DNA from 10 clones collected using QIAprep DNA isolation kit was used for 
sequencing (Qiagen, 27106).  Sequencing was completed using the GenomeLab Dye Terminator 
Cycle Sequencing (DTCS) Quick Start Kit (Beckman Coulter, 608120) in a total reaction volume 
of 20 uL using Beckman Coulter’s CEQ 8000 GeXP: 97oC for 3 minutes, 35 cycles of 96oC 
denature for 20 seconds, 50oC annealing for 20 seconds and 60oC extension for 4 minutes.  
Sequencing reactions were carried out using V-bottom, 96-well plates (Beckman Coulter, 
609801).  Samples were overlayed with light mineral oil (Sigma-Aldrich M5904).   
Statistical analysis 
For AP and cell count assays, at least three replicas were completed and compared using 
a two-tailed, repeated measures ANOVA.  Post hoc testing with a two-tailed, unpaired T-test was 
done to compare cell counts for ESCs cultured on RUCs as compared to ESCs cultured on MEFs 
in the control and 96 hours deprivation conditions.  P values of <0.05 were considered 
significant. 
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Figure 3-1 
 
 
Figure 3-1.  ESCs treatments were divided into three groups. 
ESCs in control wells (top row) were continuously supplemented with LIF/2-MCE 
(orange bars).  For the 48 hours deprivation treatment (middle row), ESCs were cultured for 72 
hours supplemented with LIF/2-MCE and for an additional 48 hours after removal of LIF/2-
MCE (green bars).  For the 96 hours deprivation (bottom row), ESCs were cultured for 24 hours 
supplemented with LIF/2-MCE and for an additional 96 hours after removal of LIF/2-MCE.  All 
feeder cells were plated 48 hours prior to plating ESCs.  Time point where ESCs were plated is 
indicated here as 0 hours. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol 
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Figure 3-2 
 
 
 
Figure 3-2.  Grid for counts of Alkaline Phosphatase-stained colonies. 
Alkaline phosphatase-stained colonies within the 2.4 cm2 area represented by the total 
surface area of all 12 boxes depicted were counted. 
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Table 3-1 
 
Table A-1.  Primer log. 
Primer sets used for semi-quantitative reverse transcriptase-polymerase chain reaction 
(RT-PCR), gel electrophoresis RT-PCR and Nanog proximal promoter methylation-specific RT-
PCR are shown.  The first set of primers was for semi-quantitative RT-PCR.  The second set of 
primers was for gel electrophoresis RT-PCR.  The third set of primers was for Nanog DNA 
methylation analysis.  Species indicates the species for which the primers were designed.  The 
accession no is that which is associated with the gene on the National Center for Biotechnology 
Information website.  Size indicates the expected product size after PCR amplification.  Position 
indicates the location of the primer sequence within the associated gene. 
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CHAPTER 4 - Results 
Alkaline phosphatase (AP) staining of ESC colonies 
As expected, culture in the absence of LIF and 2-MCE for 96 hours resulted in a decrease 
in the number of AP staining colonies (p< 0.01, figure 4-1A).  As shown in figure 4-1B, there 
was a significant difference between the number of AP stained colonies between the two feeder 
types: MEFs compared to RUCs (p< 0.01), by inspection, it is seen that MEFs have more AP-
stained colonies compared to RUCs.  Plating density of the feeder layer did not affect the number 
of AP stained colonies (p> 0.05) and the results from the two densities tested here were pooled 
(data not shown).  Culture of ESCs on RUCs under control treatment conditions which were 
continuously supplemented with LIF/2-MCE showed some irregular morphology (figure 4-1C). 
Figure 4-2A shows that there was a significant effect of feeder type x time point on the 
number of AP- stained colonies (p< 0.01).  Figure 4-2B (bottom panels) shows RUCs maintained 
the number of AP-stained colonies after LIF and 2-MCE removal.  In contrast, as shown in 
figure 4-2B (top panels), the number of AP-stained colonies decreased on MEF feeders when 
LIF and 2-MCE were removed.  These results were further evaluated by cell counts (see below). 
Cell counts after LIF removal 
Two mouse ESC lines were evaluated, D3 and LC3.  As shown in figure 4-3A, the total 
number of cells, live and dead, between the two ESC types was not different (p>0.05) despite the 
use of different counting methods for the D3 and LC3 (see methods).  There was a significant 
ESC type x feeder type interaction in the number of cells (p< 0.01), suggesting that LC3 ESCs 
grew better on the MEF feeders and as compared to D3s, and D3s grew better on the RUC 
feeders as compared to LC3s (figure 4-3B).  This result was unexpected and not investigated 
further here.   
As shown in figure 4-4A, removal of LIF and 2-MCE resulted in a significant decrease in 
the number of cells (p< 0.01).  There was no significant main effect of feeder type (p> 0.05), 
however there was a significant interaction of feeder type x treatment time (p< 0.01).  This is 
shown in Figure 4-4B.  The number of cells was greater with MEF feeders under control 
conditions (0 hr) as compared to RUC feeders (post hoc t-test, p<0.001).  However, 96 hr of LIF 
and 2-MCE deprivation resulted in the RUC feeders having significantly more cells than ESCs 
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with MEF feeders (post hoc t-test, p<0.005).  In summary, MEF feeders produced more ESCs 
than RUC feeders when maintained with LIF and 2-MCE, and MEFs were not able to maintain 
cell numbers as well as RUCs after removal of LIF and 2-MCE.   
Gel electrophoresis of RT-PCR for Nanog, Sox2 and Oct4 gene expression 
Gel electrophoresis RT-PCR for Oct4, Sox2 and Nanog suggested differences in gene 
expression after removal of LIF and 2-MCE (figure 4-5).  Specifically, Sox2 and Nanog gene 
expression appeared to be decreased after 96 hours of LIF and 2-MCE deprivation when the 
ESCs were cultured on MEFs.  In contrast, when ESCs were grown on the RUC feeder layer, 
Nanog, and to a lesser degree, Sox2 bands, appeared brighter as compared to bands from MEF 
co-cultures (compare lane 6 with lane 3).  In addition, when ESCs were cultured on RUC 
feeders, Nanog and Sox2 bands were present even after culture in the absence of LIF/2-MCE for 
96 hours.  The RT-PCR results were reevaluated using semi-quantitative RT-PCR (see below).   
Semi-quantitative RT-PCR analysis of Nanog and Sox2 gene expression 
In ESCs, when hydroxymethylbilane synthase (PBGD or HMBS) was used as the control 
gene, the delta Ct for ESCs grown on MEF feeders increased and this increase was dependent on 
the duration of LIF and 2-MCE deprivation with the highest delta Ct values after 96 hours of 
LIF/2-MCE deprivation (figure 4-6A, left panel). This indicates that the Nanog gene is 
downregulated by LIF/2-MCE removal when ESCs were grown on MEFs.  In contrast, the delta 
Ct for Nanog gene expression when ESCs were grown on RUC feeders decreased after culture 
for 96 hours in the absence of LIF/2-MCE.  This indicates that Nanog gene expression was 
maintained following LIF/2-MCE removal when ESCs were grown on RUCs.  When Nanog 
gene expression was evaluated in an independently generated set of biological samples using 18S 
as the control gene, a similar trend was seen (figure 4-6A, right panel).  The delta Ct value for 
Nanog expression again tended to increase after LIF and 2-MCE deprivation when ESCs were 
grown on MEFs.  In contrast, Nanog gene expression was maintained when ESCs were grown on 
RUCs.  These results suggested that the Nanog gene was downregulated when ESCs were grown 
on MEFs and not downregulated when ESCs were grown on RUCs.  For the Nanog semi-
quantitative RT-PCR, three control genes were evaluated: 18S, PBGD and ALAS.  18S was 
selected for the calculation of the delta Ct value for the Nanog semi-quantitative RT-PCR.  18S 
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showed the lowest Ct value of three housekeeping genes tested.  It had an average Ct value of 
13.4 across 19 different samples tested (figure 4-6B).  The standard deviation was 1.39 and the 
standard error of the mean was 0.29. 
Sox2 gene expression was also analyzed using the housekeeping gene PBGD with respect 
to feeder cell density and LIF/2-MCE treatment (figure 4-7, top).  The gene expression relative 
to PBGD shows Sox2 is downregulated in ESCs cultured on MEFs at 25,000 cells/cm2 (blue 
bars).  In contract, ESCs cultured on RUCs show an upregulation of Sox2 when ESCs were 
cultured on feeders at 12,500 cells/cm2 (red bars) and no change in Sox2 gene expression when 
feeders were plated at 25,000 cells/cm2 (green bars).  The results suggest RUCs may maintain 
expression of Sox2 in the absence of LIF/2-MCE and that Sox2 was downregulated when ESCs 
were cultured on MEFs in the absence of LIF/2-MCE.  There was no effect of density on the 
downregulation of Nanog gene expression when ESCs were cultured on MEF feeders (figure 4-
7, bottom). 
Methylation of the Nanog promoter 
To understand better what was happening to Nanog gene expression when ESCs were 
grown on the different feeders, the methylation status of the Nanog promoter was evaluated, 
since promoter methylation is known to correspond to loss of Nanog gene expression (Farthing 
et al., 2008).  The methylation of all the possible CpG dinucleotides in the proximal promoter 
from -619 bp upstream of the start site at positions -517, -495, -301, -292, -210, -200, -142 and -
15 bp were analyzed.  There was a trend for this region of the Nanog promoter to be more highly 
methylated after removal of LIF/2-MCE when ESCs were cultured on MEFs as compared to 
RUCs (figure 4-8).  When ESCs were cultured on MEFs, methylation was 5% in the control 
wells supplemented with LIF/2-MCE for the duration of the assay.  After 48 hours of LIF/2-
MCE deprivation, methylation was 9% and after 96 hours of LIF/2-MCE deprivation, 
methylation was 31% when ESCs were cultured on MEFs.  When ESCs were cultured on RUCs, 
methylation was 4% in the controls.  After 48 hours of LIF/2-MCE deprivation, methylation was 
found to be 2% and after 96 hours of LIF/2-MCE deprivation, methylation was 9% when ESCs 
were cultured on RUCs.  The analysis of the Nanog promoter supports the decrease in Nanog 
gene expression when ESCs were cultured on MEFs and the maintenance of Nanog gene 
expression when ESCs were cultured on RUCs, as seen in both RT-PCR and q RT-PCR.  
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Figure 4-1   
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Figure 4-1.  The average number of AP-stained colonies. 
A) To analyze the effect of LIF/2-MCE removal, the ESCs were treated under three 
conditions: control, 48 hour deprivation and 96 hour deprivation.  All data were combined 
irrespective of feeder cell plating density or feeder cell type and analyzed for the effects of 
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differential LIF/2-MCE treatment.  There is a decrease in the number of AP-stained colonies 
after removal of LIF/2-MCE when ESCs were cultured on a feeder layer (p-value < 0.01). 
B) To analyze the effect of feeder type, two feeder types were tested, mouse embryonic 
fibroblasts (MEFs) and rat umbilical cord matrix-derived stromal cells (RUCs).  All data were 
combined and analyzed for the effects of feeder type.  The two feeder cell types tested differ in 
the number of AP-stained colonies (p-value < 0.01).  
C) Representative photographs of AP-stained ESCs on RUCs (left) and MEFs (right).  
The AP staining of the ESCs on RUCs showed some irregular morphology (arrow heads) as 
compared to the consistent circular to oval morphology of the ESCs cultured on MEFs. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
AP, alkaline phosphatase; MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived 
stromal cell 
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Figure 4-2 
 
 
Figure 4-2.  Interaction effect of feeder type and time. 
A) To analyze the interaction effect of feeder type and LIF/2-MCE treatment, the ESCs 
were treated with LIF/2-MCE under three conditions and two feeder types were evaluated, MEFs 
and RUCs.  All data were combined irrespective of feeder cell density and analyzed for the 
interaction effect of feeder cell type and LIF/2-MCE treatment.  ESCs cultured on MEFs (blue 
line) showed a loss of AP-staining after LIF/2-MCE removal, whereas the RUCs (red line) did 
not (p-value < 0.01).   
B) Representative photographs taken using a 55 mm Nikkor macro lens.  In contrast to 
ESCs cultured on MEFs (bottom panels), ESCs cultured on RUCs (top panels) maintained the 
average number of AP-stained colonies even after LIF/2-MCE removal for 96 hours (third 
column). 
Control (left), 48 hour deprivation (middle), 96 hours deprivation (right). 
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LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
AP, alkaline phosphatase; MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived 
stromal cell 
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Figure 4-3 
 
 
Figure 4-3.  Average total cells for D3 or LC3 grown on MEFs or RUCs. 
A) To analyze the effect of ESC type, two mouse ESC types were tested, D3 and LC3. 
All data were combined irrespective of LIF/2-MCE treatment and analyzed for differences in 
average total cell counts dependent on ESC type.  There was no difference in the average total 
number of cells between the D3s and the LC3s (p-value > 0.05).  
B) The interaction effect of ESC type and feeder cell type was analyzed.  D3s (left) 
showed higher average total cell numbers when cultured on RUCs (blue bars) and LC3s (right) 
showed higher average total cell numbers when cultured on MEFs (red bars) (p-value < 0.01). 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived stromal cell 
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Figure 4-4 
 
 
Figure 4-4.  Effect of LIF/2-MCE treatment on average total cell numbers. 
A) To analyze the effect of LIF/2-MCE removal, the ESCs were treated under three 
conditions: control, 48 hour deprivation and 96 hour deprivation.  All data were combined and 
analyzed for the effect of LIF/2-MCE removal.  LIF/2-MCE removal causes a decrease in the 
average total number of cells (p-value < 0.01).  Data shown were combined data from all 
samples irrespective of ESC type, feeder cell type or feeder cell density and segregated only by 
treatment time points. 
B) To analyze the interaction effect of LIF/2-MCE treatment and feeder type, the ESCs 
were treated under three conditions as above and two feeder types were tested, MEFs and RUCs.  
The average total number of ESCs was higher when continuously supplemented with LIF/2-
MCE (control) when cultured on MEFs (red bars) (p-value < 0.005).  The average total number 
of ESCs was higher in 96 hour deprivation when cultured on RUCs (blue bars, p-value < 0.004).  
Post hoc unpaired T-test was completed for the p values indicated. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived stromal cell 
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Figure 4-5 
 
Figure 4-5.  Gel electrophoresis RT-PCR for Oct4, Nanog and Sox2 
To analyze the interaction effect of LIF/2-MCE treatment and feeder type, the ESCs were 
treated under three conditions and two feeder types were tested, MEFs and RUCs, as above and 
mRNA was collected.  Nanog gene expression when ESCs were cultured on MEFs at 12,500 
cells/cm2 (M12) appears to be downregulated after 96 hours of LIF/2-MCE deprivation.  Sox2 
gene expression appears to be expressed at a lower level when ESCs were cultured on MEFs at 
either density (M25 and M12) as compared to RUCs (orange box).  When ESCs were cultured 
on RUCs, Nanog and Sox2 gene expression was maintained.  Oct4 gene expression does not 
appear to be affected even 96 hours after LIF/2-MCE removal. 
M25 and M12 are MEFs at 25,000 and 12,500 cells/cm2, respectively. 
R12 and R25 are RUCs at 12,500 and 25,000 cells/cm2, respectively. 
Lanes 1 and 4, control conditions, supplemented continuously with LIF/2-MCE 
Lanes 2 and 5, 48 hour deprivation of LIF/2-MCE 
Lanes 3 and 6, 96 hour deprivation of LIF/2-MCE 
Lane 7, negative control, either RUCs or MEFs only, absent ESCs and lane 8, water 
control; housekeeping gene PBGD was used as the DNA loading control. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
Oct4 or POU5F1, Pit-Oct-Unc (POU) domain, class 5, transcription factor 1; Sox2, SRY (sex 
determining region Y)-box 2; PBGD or HMBS, hydroxymethylbilane synthase; cm2, square 
centimeters; MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived stromal cell 
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Figure 4-6 
 
 
Figure 4-6.  Semi-quantitative RT-PCR for Nanog gene expression 
A) Nanog gene expression was analyzed relative to two housekeeping genes, PBGD (left) 
and 18S (right) using delta Ct value.  The delta Ct values calculated using both housekeeping 
genes showed similar trends for Nanog gene expression from the cultures of ESCs on both MEFs 
(blue lines) and RUCs (red lines).  The trends show Nanog gene expression is downregulated 
after culture in MEFs in the absence of LIF/2-MCE for 96 hours as compared to the control 
treatment, and Nanog gene expression was upregulated when ESCs were cultured on RUCs in 
the absence of LIF/2-MCE for 96 hours as compared to the control treatment. 
B) Ct values from semi-quantitative RT-PCR for 18S for all cDNA samples used in this 
study.  As shown, the average Ct value was 13.4, the standard deviation was 1.39 and the 
standard error of the mean was 0.29.  If Sample 7 in not included, the standard deviation drops to 
0.9. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
Oct4 or POU5F1, Pit-Oct-Unc (POU) domain, class 5, transcription factor 1; Sox2, SRY (sex 
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determining region Y)-box 2; RT-PCR, reverse transcriptase polymerase chain reaction; PBGD 
or HMBS, hydroxymethylbilane synthase; 18S, 18S ribosomal RNA; MEF, mouse embryonic 
fibroblast; RUC, rat umbilical cord-derived stromal cell 
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Figure 4-7 
 
 
Figure 4-7.  Semi-quantitative RT-PCR analyzed with respect to feeder cell density and 
LIF/2-MCE treatment for Sox2 (top) and Nanog (bottom) gene expression. 
delta Ct values for Sox2 were calculated using Ct values for the housekeeping gene 
PBGD.  The relative gene expression analysis shows Sox2 was downregulated in ESCs cultured 
on MEFs plated at 25,000 cells/cm2 in the absence of LIF/-2MCE (blue bars).  In contract, ESCs 
show an upregulation of Sox2 in the absence of LIF/-2MCE for 96 hours when cultured on 
feeders plated at 12,500 cells/cm2 (red bars) and no change when feeders were plated at 25,000 
cells/cm2 (green bars).  
delta Ct values for Nanog were calculated using Ct values for the housekeeping gene 
18S.  Nanog gene expression analysis with respect to feeder cell density and LIF/2-MCE 
treatment showed a progressive downregulation of Nanog gene expression in the ESCs when 
cultured on MEFs plated at both 12,500 and 25,000 cells/cm2 (blue and red bars, respectively) in 
the absence of LIF/2-MCE as compared to the control treatment conditions where the culture of 
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ESCs was continusously supplemented with LIF/2-MCE.  Nanog gene expression was 
progressively upregulated when ESCs were cultured on RUCs at 25,000 cells/cm2 in the absence 
of LIF/2-MCE as compared to the control treatment. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
Sox2, SRY (sex determining region Y)-box 2; RT-PCR, reverse transcriptase polymerase chain 
reaction; PBGD or HMBS, hydroxymethylbilane synthase; 18S, 18S ribosomal RNA; cm2, 
square centimeters; MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived stromal 
cell 
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Figure 4-8 
 
Figure 4-8.  Methylation analysis of the Nanog proximal promoter region. 
To analyze the effect of LIF/2-MCE treatment on DNA methylation of the Nanog 
proximal promoter, ESCs were treated under three treatment conditions, control supplemented 
continuously with LIF/2-MCE and 48 and 96 hours deprivation conditions where ESCs were 
cultured for 48 and 96 hours, respectively, in the absence of LIF/2-MCE.  Two feeder types were 
tested as above, RUCs and MEFs.  The CpG dinucleotides in the Nanog proximal promoter 
region spanning 619 bp upstream from the start site were analyzed.  ESCs cultured on MEFs are 
shown in (A) and ESCs cultured on RUCs are shown in (B).  Nanog promoter methylation 
appears to be highest when ESCs were cultured on MEFs for 96 hours after LIF/2-MCE removal.   
MEFs and RUCs were plated at 25,000 cells/cm2. 
LIF, leukemia inhibitory factor; 2-MCE, 2-mercaptoethanol or beta-mercaptoethanol; 
cm2, square centimeters; MEF, mouse embryonic fibroblast; RUC, rat umbilical cord-derived 
stromal cell 
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CHAPTER 5 - Discussion 
Mouse embryonic stem cells (ESCs) were grown in vitro on rat umbilical cord derived 
stromal cells (RUCs) and mouse embryonic fibroblasts (MEFs) to evaluate the effects of ESC 
culture in the absence of LIF/2-MCE for 48 and 96 hours.  Previous studies showed the culture 
of ESCs in the absence of LIF resulted in the downregulation of Oct4, Sox2 and Nanog and a 
loss of alkaline phosphatase (AP) staining (Mitsui et al., 2003; Maruyama et al., 2005; Zandstra 
et al., 2000).  The effects of LIF/2-MCE removal and feeder type were assessed using AP 
staining, cell counts, RT-PCR for Oct4, Sox2 and Nanog gene expression and methylation 
analysis of the Nanog gene promoter.   Here, it was shown that when mouse ESCs were cultured 
on RUC feeders in the absence of LIF, the number of AP-stained ESC colonies was not reduced.  
Cell counts showed that the number of ESCs was higher when cultured for 96 hours in the 
absence of LIF/2-MCE on RUCs as compared to culture of ESCs on MEFs in the same 
conditions.  It was also shown that when ESCs were cultured on RUCs in the absence of LIF/2-
MCE, the ESCs showed continued expression of Oct4, Sox2 and Nanog genes and reduced 
methylation of the proximal promoter of the Nanog gene.  This suggests that RUCs, through 
undefined mechanisms, support ESC self-renewal and maintain the undifferentiated state in the 
absence of LIF/2-MCE whereas MEFs are not able to do so. 
ESCs cultured on MEFs in the control conditions where the ESCs were supplemented 
continuously with LIF/2-MCE for the duration of the 120 hour experiment showed, overall, 
higher numbers of AP-stained colonies as compared to when ESCs were cultured on RUCs under 
the same conditions.  In contrast, ESCs grown on MEFs showed the lowest number of AP-
stained colonies in the 96 hours deprivation conditions where the ESCs were cultured for 96 of 
the 120 hours in the absence of LIF/2-MCE.  In contrast, ESCs cultured on RUCs showed no 
change in the numbers of AP-stained colonies in both LIF/2-MCE treatment conditions as 
compared to the control treatment conditions.  The results from the culture of ESCs on RUCs 
differ from previous work done with MEFs which showed that removal of LIF results in loss of 
AP staining (Zandstra et al., 2000).  In the absence of LIF/2-MCE and with respect to AP-
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staining as a barometer for in vitro pluripotency, the culture of ESCs on RUCs may be superior 
to the culture of ESCs on MEFs. 
Cell counts of the D3 and LC3 mouse ESCs showed the number of cells was higher when 
ESCs were cultured on MEFs in the control condition supplemented continuously with LIF/2-
MCE as compared to ESCs cultured on RUCs under the same conditions.  This showed that with 
supplementation of LIF/2-MCE, culture of ESCs on RUCs was not equivalent to culture of ESCs 
on MEFs in terms of total cell numbers.  However, the number of cells was lowest when ESCs 
were cultured on MEFs in the 96 hour deprivation conditions where ESCs were cultured in the 
absence of LIF/2-MCE for 96 hours.  Earlier work states that LIF may not be tightly associated 
with proliferation.  However, the results here were in agreement with previous work that showed 
deficiency in signaling downstream of LIF results in a decrease in proliferation (Forrai et al., 
2006).  The cell numbers for ESCs cultured on RUCs after removal of LIF/2-MCE was higher as 
compared to cell numbers for ESCs cultured on MEFs.  It is unknown why RUCs were better 
able to support self-renewal as compared to MEFs in the absence of LIF/2-MCE.  It may be due 
to gene expression as discussed below. 
Gel electrophoresis RT-PCR analysis for Oct4, Sox2 and Nanog gene expression 
suggested that Sox2 and Nanog were expressed at lower levels when ESCs were cultured on 
MEFs as compared to expression of these genes when ESCs were cultured on RUCs.  Previous 
work has shown that removal of LIF from the culture of ESCs results in the downregulation of 
Sox2 and Nanog genes (Mitsui et al., 2003; Maruyama et al., 2005).  The continued expression 
of Oct4 gene after culture in the absence of LIF/2-MCE is in agreement with previous work 
showing maintenance of Oct4 gene expression after culture for four days in the absence of LIF.  
Longer time points may show downregulation of Oct4. 
Semi-quantitative RT-PCR for Nanog gene expression was also conducted on the same 
cDNA samples as used in the gel electrophoresis RT-PCR analysis of gene expression.  Nanog 
gene expression was found when ESCs were cultured on RUCs in the controls and treatment 
conditions and was found to be upregulated when ESCs were cultured in the absence of LIF/2-
MCE on RUCs.  Nanog gene expression was downregulated when ESCs were cultured on MEFs 
as compared to the control treatment conditions.  Sox2 gene expression was also shown to be 
downregulated when ESCs were cultured on MEFs, and was not downregulated when ESCs 
were cultured on RUCs plated at either 12,500 or 25,000 cells/cm2.  The downregulation of 
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Nanog and Sox2 seen when ESCs were cultured on MEFs is in agreement with previous work 
that shows downregulation of Nanog and Sox2 after removal of LIF (Mitsui et al., 2003; 
Maruyama et al., 2005).  As will be discussed below, the downregulation of both Sox2 and 
Nanog found here may have contributed to the reduced cell numbers of the ESCs when they 
were cultured on MEFs in the absence of LIF/2-MCE. 
DNA methylation analysis of the Nanog proximal promoter showed that the percentage 
of methylated cytosines was highest when ESCs were cultured on MEFs in the absence of LIF/2-
MCE for 96 hours.  The percentage of methylated cytosines was higher for both treatment 
conditions when ESCs were cultured on MEFs as compared to ESCs cultured on RUCs.  The 
percentage of methylated cytosines was 9% and 2% for ESCs cultured in the absence of LIF/2-
MCE for 48 hours on MEFs and RUCs, respectively. 
The above results suggest that RUCs prevent the differentiation of mouse ESCs in vitro 
in the absence of LIF.  However, the results also suggest that with continued supplementation of 
LIF, expansion of ESCs may be superior on the MEFs.  The differences in the number of AP-
stained colonies and cell numbers when ESCs were cultured for 96 hours in the absence of 
LIF/2-MCE on RUCs as compared to ESCs cultured on MEFs may be associated with 
differences in the expression levels of the genes associated with the pluripotent state, Oct4, Sox2 
and Nanog.   
It should be noted that the undifferentiated state, of which AP-staining is indicative, and 
proliferation are separable.  Nanog and Sox2 are required to prevent the differentiation of mouse 
ESCs.  Nanog and Sox2 have also been found in previous studies to have effects on proliferation 
(Torres and Watt, 2008;Wang et al., 2008a;Wang et al., 2008b).  Here, we found that ESCs 
cultured on RUCs maintain the level of Nanog and Sox2 gene expression after removal of LIF/2-
MCE.  Given the previous work and the finding here that Nanog and Sox2 gene expression were 
not downregulated when ESCs were cultured on RUCs in the absence of LIF/2-MCE could 
explain the higher numbers of total cells found when ESCs were cultured on RUCs in the 
absence of LIF/2-MCE.  The downregulation of Sox2 and Nanog gene expression seen after 
culture of ESCs on MEFs in the absence of LIF/2-MCE for 96 hours could also explain the 
reduced number of AP-stained colonies as well as the reduced number of cells and that the 
reduction in the number of AP-stained colonies may be due mainly to the reduced proliferation 
of cells. 
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It is possible that RUCs produce LIF.  Human umbilical cord matrix-derived stromal cells 
(HUCs) have been shown to secrete LIF (Friedman et al., 2007).  Other studies have found 
contrasting effects of LIF removal on proliferation (Raz et al., 1999; Mitsui et al., 2003).  In the 
Raz et al study, one ESC line showed a two-fold decrease in the proliferation of ESCs cultured 
for 96 hours in the absence of LIF as compared to ESCs supplemented with LIF.   
An important point here is that these studies used ESCs derived from different strains of 
mice.  This is analogous to the predisposition of individuals with a genotype that renders them 
more susceptible to particular diseases.  This should be considered when comparing results here 
with previous work since the genotype of the ESCs here are different from that used in the Raz et 
al. study and the effects of LIF on proliferation found in the Raz et al. study was found to be 
strain dependent.  However, this previous work could explain the five-fold difference in the total 
number of cells observed here between the control conditions and the 96 hour deprivation 
conditions when ESCs were cultured on MEFs.  It was also interesting that the cell numbers 
when ESCs were cultured on RUCs was nearly two-fold higher in the control conditions as 
compared to the 96-hour deprivation conditions suggesting a similar effect of LIF withdrawal 
here as that found in the Raz et al. study. 
The downregulation in Nanog gene expression after LIF/2-MCE removal may be 
associated with methylation of the Nanog proximal promoter.  As shown in previous studies with 
Oct4 where the proximal promoter of the Oct4 gene was shown to be progressively methylated 
with significant methylation after 4 days of retinoic acid treatment, the proximal promoter for 
Nanog in the ESCs cultured on MEFs in the absence of LIF/2-MCE for 96 hours was more 
methylated as compared to the proximal promoter for ESCs cultured on RUCs (Gu et al., 2006).  
The highest level of methylation seen in the ESCs cultured on RUCs was 9% as compared to 
31% for ESCs cultured on MEFs.  The methylation data was in agreement with the decrease in 
Nanog gene expression seen here in both the RT-PCR and the semi-quantitative RT-PCR when 
ESCs were cultured on MEFs for 96 hours after removal of LIF/2-MCE.  It was also in 
agreement with the continued expression of the Sox2 gene in ESCs cultured on RUCs in the 
absence of LIF/2-MCE at the same or higher levels as compared to control treatment conditions. 
The most glaring limitation of the study was the simultaneous removal of LIF and 2-
MCE, as 2-MCE has shown effects on proliferation and apoptosis in porcine and bovine embryos 
(Funahashi 2005; Park et al., 2004).  The major limitations of this work include the use of mouse 
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embryonic fibroblasts (MEFs) rather than rat embryonic fibroblasts.  The species differences 
between the MEFs and RUCs added an unintentional variable.  The limitations of this work also 
include the absence of a mechanistic evaluation of the effects of LIF removal.  For example, 
knocking out the receptor for LIF in the RUCs would help to determine the mechanism by which 
the removal LIF may have affected the cell numbers when ESCs were cultured on RUCs.  Gene 
expression analysis of the ESCs at time points coincident with the timing of the switch from the 
ESC medium to the MEF medium would have benefited the study.  Such a study would be 
illustrative of the possible effects of the removal of LIF and 2-MCE on the cell cycle and 
proliferation.  Another limitation of the study was that given the increase in methylation seen in 
the Nanog proximal promoter after culture on MEFs in the absence of LIF/2-MCE, for the 
purposes of methylation analysis, longer time points may be helpful since all the cytosines were 
not methylated here.  The Nanog proximal promoter was completely methylated in sperm and 
78% methylated in trophoblast stem cells (Farthing et al., 2008; Hattori et al., 2007).  Adding 
longer time points may increase the percentage of methylation of the Nanog proximal promoter 
in the ESCs cultured on MEFs accompanied by an increased downregulation of the expression of 
the Nanog gene.  The study would have benefited greatly from additional replicates for gel 
electrophoresis and semi-quantitative RT-PCR and DNA methylation analysis and Sox2 
proximal promoter methylation analysis would have been beneficial since gel electrophoresis 
indicated that the downregulation of Sox2 gene expression may have been greater than 
downregulation of the Nanog gene expression.  Finally, the study would have benefited from a 
direct measure of pluripotency, i.e., showing germline transmission of the ESCs cultured on 
RUCs after blastocyst injection. 
In future work, it would be interesting to examine how the RUCs were able to maintain 
both AP staining and ESC numbers in the absence of LIF/2-MCE.  As previous work has shown, 
it may be signaling unassociated with LIF and associated with the Sox2 and Nanog genes.  This 
future work could address the difference between ESC self-renewal, which is the continued 
propagation of the cells in the pluripotent state, and proliferation which can occur during 
differentiation from the pluripotent state. 
Finally, D3 co-culture on RUCs show some irregularities in morphology.  In contrast to 
D3s cultured on MEFs which show a smooth, circular to oval morphology, D3s cultured on 
RUCs show a tendency for protrusions, leading to some elongate colonies (not shown).  
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Preliminary studies of D3 RUC co-culture followed by passage to MEFs show D3s regain the 
smooth, circular to oval morphology after RUC co-culture (not shown).  An extracellular matrix, 
or basement membrane, encapsulating the colony may be responsible for the smooth, oval 
morphology (not shown).  Sox2 may also be involved as overexpression causes differentiation of 
ESCs after 72 hours (Kopp et al., 2008).  The continued expression of Sox2 when ESCs were 
cultured on RUCs in the absence of LIF/2-MCE could explain the higher incidence of mixed AP-
stained colonies (data not shown).   
Overall, this study showed that RUCs can promote the in vitro pluripotent state in the 
absence of LIF/2-MCE, as indicated by the continued gene expression of the pluripotency 
markers Oct4, Sox2, Nanog and the presence of AP staining after removal.  The gene expression 
for the ESCs cultured on the RUCs also showed a profile distinct from the gene expression 
profile of the ESCs cultured on the MEFs.  Therefore, the culture of ESCs on RUCs represents a 
simple model for the in vitro study of molecules at the core of the pluripotency network, 
especially with respect to DNA methylation analysis of the Nanog gene proximal promoter.  
Given the differential gene expression profile found in this study, comparing the downstream 
effects of Oct4, Sox2 and Nanog differential expression may be possible.  Ultimately, this in 
vitro model may reveal threshold levels of transcription factors for the maintenance of the 
pluripotent state, an active area of current research.  As mentioned in the literature review, subtle 
changes in the levels of gene expression result in changes in the gene expression of Oct4, Sox2 
and Nanog (Niwa et al., 2000; Pan et al., 2006; Leonhardt et al., 1992).  Understanding how the 
levels of gene expression of Oct4, Sox2 and Nanog, which have been shown to have complex 
interactions, can help further delineate that which was described recently as the “ground state of 
pluripotency” (Medeiros et al., 2009; Ying et al., 2008).  Studies such as the co-
immunoprecipitation used in the Medeiros study, applied in this in vitro model could help in this 
regard by uncovering Sox2 and Nanog protein-associated molecules integral to the decision to 
drive or repress a particular fate in the differentiation of ESCs. 
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 Appendix A - ANOVA Tables 
Table A-1 
 
Total Number of AP-stained Colonies ANOVA 
ANOVA for main effects are shown.  The p-value of 0.0087 is associated with Figure 4-
1A indicating that there was an effect of removal of LIF on the number of AP-stained colonies.  
The p-value 0.9308 indicates that feeder density had no effect on the number of AP-stained 
colonies.  The p-value of 0.1021 indicates that there was no interaction effect between removal 
of LIF/2-MCE and feeder density. 
 ANOVA, analysis of variance; AP, alkaline phosphatase; LIF, leukemia inhibitory factor; 
2-MCE, 2-mercaptoethanol or β-mercaptoethanol 
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Table A-2 
 
 
Total Cell Counts ANOVA 
 ANOVA for main effects are shown.  The p-value of 0.4386 indicates that ESC type had 
no effect on the average total number of cells.  The p-value of 0.4506 indicates that feeder type 
had no effect on the average total number of cells.  The p-value of 0.0068 indicates that there 
was an interaction effect between ESC type and feeder type (this was not pursued). 
 ANOVA, analysis of variance; ESC, embryonic stem cell 
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Appendix B - RNA Log 
Table B-1 
 
 52
RNA sample log showing sample description, sample concentration, 260/280 quality ratio, 
volume and total amount of RNA in nanograms. 
 RNA, ribonucleic acid 
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